has been cited by the following article(s):
|
[1]
|
Quantification of Seven Known and Several Unknown Impurities from Fluticasone Furoate and Oxymetazoline Hydrochloride Nasal Spray Product Using RP-HPLC UV Methodology
Chromatographia,
2025
DOI:10.1007/s10337-025-04390-y
|
|
|
|
|
[2]
|
Development with greenness evaluation and validation of stability indicating ion-pair reverse phase HPLC method for determination of related substances and assay of Nirmatrelvir drug substance
Analytical Chemistry Letters,
2025
DOI:10.1080/22297928.2025.2450278
|
|
|
|
|
[3]
|
DEVELOPMENT AND VALIDATION OF DEFERASIROX-RELATED SUBSTANCE METHOD IN SOLID DOSAGE FORMS USING HPLC
International Journal of Applied Pharmaceutics,
2025
DOI:10.22159/ijap.2025v17i2.53465
|
|
|
|
|
[4]
|
Nano-Analytical Techniques in Pharmaceutical Analysis
Jordan Journal of Pharmaceutical Sciences,
2025
DOI:10.35516/jjps.v18i2.2631
|
|
|
|
|
[5]
|
Puerarin—A Promising Flavonoid: Biosynthesis, Extraction Methods, Analytical Techniques, and Biological Effects
International Journal of Molecular Sciences,
2024
DOI:10.3390/ijms25105222
|
|
|
|
|
[6]
|
LC and LC-MS/MS Studies for Identification and Characterisation of Related Substances and Degradation Products of Abrocitinib
Toxicology International,
2024
DOI:10.18311/ti/2024/v31i2/36370
|
|
|
|
|
[7]
|
Pharmaceutical Impurities and Their Regulatory Aspects with a Special Focus on Genotoxic Impurities
International Journal of Pharmaceutical Research and Allied Sciences,
2024
DOI:10.51847/kEAkHOrcWf
|
|
|
|
|
[8]
|
Regulatory Considerations of Pharmaceutical Impurities with Emphasis on Genotoxic Impurities
Pharmaceutical Sciences and Drug Design,
2024
DOI:10.51847/ck2yogXhAS
|
|
|
|